Company intelligence / Profile preview

Vitex Pharmaceuticals

Eastern Creek, New South Wales (NSW), Australiavitex.com ↗

Ownership: Private
Employees: ~300
Development stage: Phase 3

Overview

Vitex is Australia’s leading contract manufacturer of vitamins, minerals and nutritional supplements. They operate one of the largest facilities in Australia for solid dose complementary medicines and serve both domestic and international markets. The company does not develop its own therapeutics but manufactures products for major brands worldwide.

Therapeutic areas: Other
Modalities: VitaminsMineralsNutritional supplements (including tablets, powders, hardgel and softgel capsules)Complementary medicines
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

INACTINE

Phase 3

Indications: Blood pathogen inactivation

Beyond the preview

Go deeper on Vitex Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitex Pharmaceuticals.

Explore the full profile